1 / 41

NOTES: CH 18 part 2 - The Molecular Biology of Cancer

NOTES: CH 18 part 2 - The Molecular Biology of Cancer. Certain genes normally regulate cell growth & division – the cell cycle. ● mutations that alter these genes in somatic cells can lead to cancer ● mutations may be spontaneous or the result of exposure to a MUTAGEN / CARCINOGEN.

dawsone
Download Presentation

NOTES: CH 18 part 2 - The Molecular Biology of Cancer

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. NOTES: CH 18 part 2 -The Molecular Biology of Cancer

  2. Certain genes normally regulate cell growth & division – the cell cycle. ● mutations that alter these genes in somatic cells can lead to cancer ● mutations may be spontaneous or the result of exposure to a MUTAGEN / CARCINOGEN

  3. GENES & CANCER: ●ONCOGENES = cancer-causing genes, first found in certain retroviruses ● subsequently, close counterparts have been found in the genomes of humans & other animals ●PROTO-ONCOGENES = normal cellular genes that code for proteins that stimulate normal cell growth & division.

  4. How Might a Proto-Oncogene Become an Oncogene? ● In general, an oncogene arises from a genetic change that leads to an INCREASE in either:  the amount of the proto-oncogene’s protein product;  the intrinsic activity of each protein molecule

  5. The genetic changes that convert proto-oncogenes to oncogenes fall into 3 categories: 1) Movement of DNA within the genome; 2) Amplification of a proto-oncogene; 3) Point mutation in an oncogene (or one of its control elements).

  6. 1) Movement of DNA within the genome: ● chromosomes may break and then rejoin incorrectly, translocating fragments from 1 chromosome to another ● a proto-oncogene may now lie adjacent to a more active promoter ● or, an active promoter may move by transposition to the region just upstream of the proto-oncogene, increasing its expression

  7. 2) Amplification of a proto-oncogene : ● increases the # of copies of the gene in a cell through repeated gene duplication

  8. 3) Point mutation in a proto-oncogene (or a control element): ● changes the gene’s protein product to one that is more active or more resistant to degradation than the normal protein… ● or could be a point mutation in the promoter of a gene, causing an increase in its expression; …all of these changes can lead to abnormal stimulation of the cell cycle and put the cell on the path to malignancy.

  9. 3) Point mutation in a proto-oncogene :

  10. ● the changes considered thus far affect growth-stimulating proteins… ● however, changes in genes whose normal products INHIBIT cell division also contribute to cancer… ● such genes are called: TUMOR-SUPPRESSOR GENES

  11. Tumor-Suppressor Genes: ● the proteins encoded by these genes normally help to prevent uncontrolled cell growth. ● any mutation that decreases the normal activity of a tumor-suppressor protein may contribute to the onset of cancer (stimulates growth through the absence of suppression!)

  12. Tumor-Suppressor Genes – What Do They Do? They may encode a protein that… ● repairs damaged DNA (prevents cell from accumulating cancer-causing mutations) ● controls the adhesion of cells to each other or to an extracellular matrix (proper cell anchorage is crucial in normal tissues) ● are components of cell-signaling pathways that inhibit the cell cycle

  13. 2 “key” cancer-linked genes: ● ras proto-oncogene ● p53 tumor-suppressor gene

  14. ras proto-oncogene: ● mutations in the ras gene are found in about 30% of human cancers ● the product is the Ras protein ● the Ras protein is a G protein that relays a growth signal from a growth factor receptor on the plasma membrane to a cascade of protein kinases

  15. ras proto-oncogene: ● the response: synthesis of a protein that stimulates the cell cycle ● many ras oncogenes have a point mutation that leads to a hyperactive version of the Ras protein that signals on its own… ● the outcome: excessive cell division!

  16. p53 tumor-suppressor gene: ● mutations in the p53 gene are found in about 50% of human cancers ● the product of the p53 gene is a protein that is transcription factor that promotes synthesis of growth-inhibiting proteins… ● so, a mutation knocking out the p53 gene can lead to excessive cell growth & cancer ● the p53 protein acts in several ways to prevent a cell from passing on mutations or damaged DNA:

  17. p53 gene: ● the p53 gene has been called the “guardian angel of the genome”… ● once the p53 gene is activated – for example, by DNA damage – the p53 protein functions as an activator for several other genes…

  18. p53 protein: (1) activates a gene (p21) whose product halts the cell cycle, allowing time for the cell to repair any damaged DNA; (2) can turn on genes directly involved in DNA repair; (3) Activates expression of a group of miRNAs, which in turn inhibit the cell cycle; (4) when DNA damage is irreparable, p53 activates “suicide” genes, whose protein products cause cell death by APOPTOSIS

  19. p53 protein: ● thus, p53 acts in several ways to prevent a cell from passing on mutations due to DNA damage; ● if mutations do accumulate and the cell survives through many divisions (as is more likely if the p53 tumor-suppressor gene is defective or missing), cancer may ensue.

  20. Multiple mutations underlie the development of cancer. ● more than 1 somatic mutation is generally needed to produce a full-fledged cancer cell; ● this may help explain why the incidence of cancer increases greatly with age… ● if cancer is the result of an accumulation of mutations, & if mutations occur throughout life, then the longer we live, the more likely we are to develop cancer.

  21. Colorectal Cancer: ● about 135,000 new cases per year in the U.S. ● develops gradually – first sign usually a POLYP (small, benign growth in colon lining) ● the tumor grows and eventually may become MALIGNANT ● a malignant tumor will typically have cells with multiple oncogenes activated and multiple tumor-suppressor genes inactivated

  22. RememberTELOMERES?  ● in many malignant tumors, the gene for TELOMERASE is activated… ● this enzyme prevents the erosion of the ends of chromosomes (the telomeres), thus removing a natural limit on the # of times the cells can divide…the tumor cells just keep on growing!

  23. Breast Cancer: ● in 5-10% of breast cancer cases, there is evidence of a strong inherited predisposition ● in 1994-1995, researcher identified 2 genes involved these breast cancers: BRCA1 and BRCA2 ● both are considered tumor-suppressor genes (their wild-type alleles protect against breast cancer) ● what the normal products of BRCA1 and BRCA2 actually do is still unknown…it seems as though they are both involved in the cell’s DNA damage repair pathway.

  24. Viruses & Cancer: ● viruses seem to play a role in about 15% of human cancer cases worldwide EXAMPLES: ● retroviruses  some forms of leukemia ● hepatitis viruses  some liver cancers ● HPV  cancer of the cervix

More Related